Andelyn Biosciences
Chemicals & Related Products · Ohio, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
575 Childrens Xrd, Columbus, Ohio, 43215...Website
www.andelynbio.comRevenue
$45.2 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
4
1
1
1
1
1
About Andelyn Biosciences
Andelyn Biosciences is a full-service cell and gene therapy contract development and manufacturing organization (CDMO) that specializes in viral vector and plasmid manufacturing, process development, and analytical services. With a proven track record of over 450 GMP batches and more than 75 INDs approved, the company is dedicated to advancing innovative therapies for rare diseases. Their AAV Curator Platform and commitment to scientific excellence enable efficient and successful gene therapy programs. Andelyn partners with various organizations to accelerate the development and commercialization of life-changing genetic therapies.Explore more
Andelyn Biosciences Org Chart
JR
Project Management Office & Operational Excel...
RV
Manufacturing Science & Technology Head
ME
Director, Manufacturing
LS
Associate Director, Supply Chain & Manager, S...
CB
Associate Director, Cleaning Operations & Doc...
BC
Associate Director, QC
RL
Associate Director, Maintenance & Facilities
JC
Associate Director, Program Management
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Andelyn Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Andelyn Biosciences has new funding data
Andelyn Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Andelyn Biosciences launches new products
Check if Andelyn Biosciences has recently received funding, and reach out quickly before it becomes old news!
Check out if Andelyn Biosciences is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Andelyn Biosciences
Website visits: Recent activity has been detected on your website
Click to see if Andelyn Biosciences had a recent Job posting/layoffs
Earning: See what the market has to say on Andelyn Biosciences recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Andelyn Biosciences
Compare insights from companies similar to Andelyn Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Andelyn Biosciences is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Andelyn Biosciences is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Andelyn Biosciences.
Andelyn Biosciences Tech Stack
A closer look at the technologies used by Andelyn Biosciences
See more technologies
Most Recent Scoops
Person-Based
Manufacturing Operations
Person-Based
Certifications, Company Culture & Policy, HR Operations
Event
Product Marketing, Events, Sales, Search, Laboratory Operations, Medical Research, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Operations, Operations
Event
Product Marketing, Events, Sales, Search, Laboratory Operations, Medical Research, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Operations, Operations
Person-Based
Andelyn Biosciences News & Media
Andelyn Biosciences and ENCell Co., Ltd Announce Strategic Partnership to Expand Global Reach of Gene Therapy Manufacturing
Strategic collaboration creates a seamless US-APAC manufacturing corridor, enabling local production for global clinical trials and enhancing patient access to next-generation medicines. COLUMBUS, Ohio and SEOUL, Republic of Korea, April 21, 2026 /PRNewswire/ -- Andelyn Biosciences,...Andelyn Biosciences to Apply the AAV Curator® Platform to Manufacture Clinical Grade AAV for Drake Rayden Foundation for the Treatment of Nonketotic Hyperglycinemia
COLUMBUS, Ohio, Feb. 17, 2026 /PRNewswire/ -- Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has been selected by Drake Rayden Foundation to apply the AAV Curator® Platform to manufacture clinical...Andelyn Biosciences Announces Partnership with Jaguar Gene Therapy to Provide Late-Stage PPQ Manufacturing
Partnership will Support Advancement of Jaguar's JAG201 Clinical-Stage Investigational Gene Therapy Targeting a Monogenic Cause of Autism Spectrum Disorder Known as Phelan-McDermid Syndrome COLUMBUS, Ohio, Dec. 8, 2025 /PRNewswire/ -- Andelyn Biosciences, a leading and patient-focused...Solid Biosciences Announces Licensing Agreement with Andelyn Biosciences for the Use of Proprietary Next-Generation Capsid AAV-SLB101
- Non-exclusive license providing Solid’s proprietary, next-generation capsid, AAV-SLB101, to Andelyn Biosciences, a full-service cell and gene therapy Contract Development and Manufacturing Organization (CDMO) - - AAV-SLB101 has been generally well tolerated in the 23 participants dosed in the Phase 1/2 INSPIRE DUCHENNE clinical trial as of a safety cutoff of October 31, 2025 -
Read more news
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Andelyn Biosciences
Sign Up For FreeTo access detailed company insights
Andelyn Biosciences is a full-service cell and gene therapy contract development and manufacturing organization (CDMO) that specializes in viral vector and plasmid manufacturing, process development, and analytical services. With a proven track record of over 450 GMP batches and more than 75 INDs approved, the company is dedicated to advancing inno... Read More
